233 related articles for article (PubMed ID: 20931338)
1. Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.
Franz M; Grün K; Richter P; Brehm BR; Fritzenwanger M; Hekmat K; Neri D; Gummert J; Figulla HR; Kosmehl H; Berndt A; Renner A
Histochem Cell Biol; 2010 Nov; 134(5):503-17. PubMed ID: 20931338
[TBL] [Abstract][Full Text] [Related]
2. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
Franz M; Matusiak-Brückner M; Richter P; Grün K; Ziffels B; Neri D; Maschek H; Schulz U; Pfeil A; Jung C; Figulla HR; Gummert J; Berndt A; Renner A
J Mol Histol; 2014 Oct; 45(5):519-32. PubMed ID: 24792713
[TBL] [Abstract][Full Text] [Related]
3. Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection.
Franz M; Berndt A; Grün K; Richter P; Kosmehl H; Neri D; Gummert J; Figulla HR; Brehm BR; Renner A
J Heart Lung Transplant; 2011 Jan; 30(1):86-94. PubMed ID: 20952210
[TBL] [Abstract][Full Text] [Related]
4. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
[TBL] [Abstract][Full Text] [Related]
5. Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.
Franz M; Grün K; Betge S; Rohm I; Ndongson-Dongmo B; Bauer R; Schulze PC; Lichtenauer M; Petersen I; Neri D; Berndt A; Jung C
Oncotarget; 2016 Dec; 7(49):81241-81254. PubMed ID: 27835899
[TBL] [Abstract][Full Text] [Related]
6. Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.
Booth AJ; Wood SC; Cornett AM; Dreffs AA; Lu G; Muro AF; White ES; Bishop DK
J Pathol; 2012 Mar; 226(4):609-18. PubMed ID: 21960174
[TBL] [Abstract][Full Text] [Related]
7. Chronic cardiac allograft rejection: critical role of ED-A(+) fibronectin and implications for targeted therapy strategies.
Franz M; Neri D; Berndt A
J Pathol; 2012 Mar; 226(4):557-61. PubMed ID: 22102444
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis.
Baldinger A; Brehm BR; Richter P; Bossert T; Gruen K; Hekmat K; Kosmehl H; Neri D; Figulla HR; Berndt A; Franz M
Histochem Cell Biol; 2011 May; 135(5):427-41. PubMed ID: 21479812
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.
Franz M; Doll F; Grün K; Richter P; Köse N; Ziffels B; Schubert H; Figulla HR; Jung C; Gummert J; Renner A; Neri D; Berndt A
Int J Cardiol; 2015 Sep; 195():311-22. PubMed ID: 26056964
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant.
Subramanian SV; Kelm RJ; Polikandriotis JA; Orosz CG; Strauch AR
Cardiovasc Res; 2002 Jun; 54(3):539-48. PubMed ID: 12031699
[TBL] [Abstract][Full Text] [Related]
13. Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin.
Franz M; Hilger I; Grün K; Kossatz S; Richter P; Petersen I; Jung C; Gummert J; Figulla HR; Kosmehl H; Neri D; Berndt A; Renner A
J Heart Lung Transplant; 2013 Jun; 32(6):641-50. PubMed ID: 23701854
[TBL] [Abstract][Full Text] [Related]
14. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation.
Ma S; Yang D; Li D; Tang B; Sun M; Yang Y
Biochem Biophys Res Commun; 2011 Jun; 409(2):321-7. PubMed ID: 21586275
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
[TBL] [Abstract][Full Text] [Related]
16. Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.
Coito AJ; Brown LF; Peters JH; Kupiec-Weglinski JW; van de Water L
Am J Pathol; 1997 May; 150(5):1757-72. PubMed ID: 9137099
[TBL] [Abstract][Full Text] [Related]
17. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.
Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H
Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy.
Kitagawa-Sakakida S; Fukushima N; Sawa Y; Horiguchi K; Doi T; Shirakura R; Matsuda H
J Heart Lung Transplant; 2005 Dec; 24(12):2068-74. PubMed ID: 16364851
[TBL] [Abstract][Full Text] [Related]
19. [Effect of vascular smooth muscle alpha-actin on cardiac allograft vasculopathy and fibrosis].
Zhang M; Yang J; Hu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):323-6. PubMed ID: 19411749
[TBL] [Abstract][Full Text] [Related]
20. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
